While the United States government shut down lasted only one business day, review and approval events in the biopharma world seem to have experience a more extended lapse. Yes, it was a slow week, but there was still enough news that it needs to be presented in brief:
The US FDA gave its blessing to Advanced Accelerator Applications SA's Lutathera (lutetium Lu 177 dotatate), marking the agency's...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?